Kiniksa Pharmaceuticals, Ltd.
Lexington, Massachusetts, United States · Biopharma, Biotechnology, Healthcare
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Lexington, Massachusetts, United States
- Employees
- 428
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Public (KNSA)
- Website
- www.kiniksa.com
- Company page
Recent activity at Kiniksa Pharmaceuticals, Ltd.
- : Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO
- : SEC 8-K (5.02):
- : SEC 8-K (1.01):
Employee benefit plans
Kiniksa Pharmaceuticals, Ltd. files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Kiniksa Pharmaceuticals, Ltd.: questions and answers
What does Kiniksa Pharmaceuticals, Ltd. do?
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Where is Kiniksa Pharmaceuticals, Ltd. headquartered?
Kiniksa Pharmaceuticals, Ltd. is headquartered in Lexington, Massachusetts, United States.
How many employees does Kiniksa Pharmaceuticals, Ltd. have?
Kiniksa Pharmaceuticals, Ltd. has about 428 employees.
What is the latest news on Kiniksa Pharmaceuticals, Ltd.?
On Oct 22, 2026, Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO
Is Kiniksa Pharmaceuticals, Ltd. a public company?
Yes. Kiniksa Pharmaceuticals, Ltd. is publicly traded under the ticker KNSA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy